Results 151 to 160 of about 101,747 (197)

NFAT single-deficient murine T cells reduce the risk of aGvHD while controlling cytomegalovirus infection. [PDF]

iScience
Hundhausen N, Majumder S, Xiao Y, Haeusl SS, Goehler H, Seal R, Chiarolla CM, Rosenwald A, Eyrich M, Cicin-Sain L, Berberich-Siebelt F.   +10 more
europepmc   +1 more source

How Should Cytomegalovirus Infection Be Managed in Allogeneic Hematopoietic Stem Cell Transplant Recipients? A Clinical Grand Round. [PDF]

Infect Chemother
Nho D, Lee R, Cho SY, Lee DG.
europepmc   +1 more source

Population pharmacokinetics and exposure-response relationships of maribavir in transplant recipients with cytomegalovirus infection. [PDF]

J Pharmacokinet Pharmacodyn
Song IH, Chen G, Hayes S, Farrell C, Jomphe C, Gosselin NH, Sun K.   +6 more
europepmc   +1 more source

Taming the transplant troll: Exploring racial and ethnic disparities in cytomegalovirus infection among kidney transplant patients. [PDF]

PLoS One
Cabanilla MG, Dauenhauer A, St John B, Hill D, Larson J.   +4 more
europepmc   +1 more source

Multifaceted profiling of virus-specific CD8 T cells reveals distinct immune signatures against cytomegalovirus infection states during pregnancy. [PDF]

iScience
Taguchi A, Misumi F, Teraguchi S, Nagamatsu T, Sakakibara S, Otani T, Ichinose M, Priest D, Nakajima K, Nakamura J, Sawada R, Suzutani T, Ikeda T, Nagura Y, Iriyama T, Okuzaki D, Okazaki H, Wing JB, Hirota Y, Osuga Y.   +19 more
europepmc   +1 more source